Latest Artificial Intelligence News

Algorae Pharmaceuticals has advanced its AI drug discovery capabilities with the launch of AlgoraeOS v2 and secured key commercial partnerships, including a $3 million debt facility to support expansion in Australia and New Zealand.

Top End Energy has strategically expanded into the US AI data center sector, positioning itself as a key land and energy partner to meet surging power demands.

Clever Culture Systems has expanded its APAS Independence installed base to 27 instruments globally and surpassed $1 million in annual recurring revenue, underpinned by strong sales momentum and customer validation.

Strategic Elements Ltd reports steady progress in its cutting-edge ventures across automation, AI, and material science, supported by a strong cash position and government-backed innovation incentives.

Argenica Therapeutics has unveiled compelling AI-driven results confirming ARG-007’s significant benefits in severe acute ischemic stroke patients, setting the stage for a precision-focused Phase 2b trial.

TZ Limited reported a quarterly cash outflow of A$790,000 impacted by payment timing but maintains full-year revenue guidance amid strategic advances in smart locker and data centre security sectors.

HeraMED Limited has completed a $3.2 million placement to fund its global rollout of digital maternity care solutions, backed by new and existing institutional investors.

Raiz Invest has reported a record $2.1 billion in funds under management, driven by strong growth in its Plus and Kids products, while outlining an ambitious 2026 roadmap featuring AI enhancements and new trading capabilities.

DroneShield Limited has reported a stellar 277% revenue surge in FY2025, underpinned by a booming SaaS segment and a robust $2.09 billion sales pipeline. The company is scaling manufacturing and capitalising on new US legislation to expand its counter-drone technology footprint.

Pureprofile has reported record first-half FY26 results, driven by strong international expansion and AI-powered platform growth, prompting an upgrade to its full-year revenue guidance.

Cyclopharm’s Technegas has been recognised as the preferred ventilation agent in a pivotal draft US lung imaging guideline, signalling a major boost for its adoption in American clinical practice.

Green & Gold Minerals reports compelling high-grade silver alongside gold at Mt Wandoo, boosting the Chillagoe project's resource potential and advancing mining study prospects.